Etiology and Outcome of Isolated Fetal Ascites: A Systematic Review. 2021

Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
Department of Obstetrics & Gynecology, Monmouth Medical Center, Long Branch, New Jersey; the Department of Obstetrics & Gynecology, New York Medical College, Valhalla, New York; the Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, Weill Cornell Medicine, New York, New York; the Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC; the Department of Biochemistry, Robert-Debré University Hospital, APHP, Paris, France; the Departamento de Obstetrícia e Ginecologia, Hospital das Clinicas da FMUSP, São Paulo, Brazil; the Department of Obstetrics and Gynecology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; the Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Eastern Virginia Medical School, Norfolk, Virginia; and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania.

To describe the etiology of isolated fetal ascites and associated perinatal outcomes, and to assess the progression of isolated fetal ascites to fetal hydrops. PubMed, Cochrane Library, Scopus, and ClinicalTrials.gov databases were searched using the following keywords: "fetus" OR "foetal" OR "fetal" OR "foetus" AND "ascites" from inception to February 2020. The search was limited to the English language. A total of 1,983 articles were identified through the search strategy. All studies containing five or more cases of isolated fetal ascites were included. Eleven studies, involving 315 cases of isolated fetal ascites, were eligible for inclusion in this systematic review. All included studies were evaluated using the tool for evaluating the methodologic quality of case reports and case series described by Murad et al. Data were summarized using narrative review and descriptive statistics. Two-tailed Fisher exact P values calculated from hypergeometric distribution were used to compare outcome by etiology. CIs were calculated with Clopper-Pearson exact binomial interval. The etiologies of isolated fetal ascites are genitourinary (24%), gastrointestinal (20%), viral or bacterial infections (9%), cardiac (9%), genetic disorders not otherwise categorized (8%), chylous ascites (6%), metabolic storage disorders (3%), other structural disorders (4%), other causes (4%) and idiopathic (13%). Survival is most favorable for cases of isolated fetal ascites as a result of chylous (100%), idiopathic (90%), gastrointestinal (77%) and genitourinary (77%) etiologies. Survival is least favorable for fetuses with isolated fetal ascites as a result of structural disorders (25%), cardiac etiology (32%) and metabolic storage disorders (33.3%). When pregnancy terminations were excluded, survival rates were similar between fetuses diagnosed at or after 24 weeks of gestation compared with those diagnosed at less than 24 weeks (74% vs 61%, P=.06). Progression of fetal ascites to fetal hydrops occurred in 6.6% (95% CI 3.6-9.6%) (17/259) of cases when pregnancies that were terminated were excluded. Isolated fetal ascites has a diverse etiology. Outcome is related to the etiology of isolated fetal ascites. In the majority of cases, fetal ascites does not progress to fetal hydrops. PROSPERO, CRD42020213930.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D005260 Female Females
D005313 Fetal Death Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH. Fetal Mummification,Fetal Demise,Death, Fetal,Deaths, Fetal,Demise, Fetal,Fetal Deaths,Mummification, Fetal
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.
D015160 Hydrops Fetalis Abnormal accumulation of serous fluid in two or more fetal compartments, such as SKIN; PLEURA; PERICARDIUM; PLACENTA; PERITONEUM; AMNIOTIC FLUID. General fetal EDEMA may be of non-immunologic origin, or of immunologic origin as in the case of ERYTHROBLASTOSIS FETALIS. Edema, Fetal,Fetal Edema,Fetal Hydrops,Familial Non-Immune Hydrops Fetalis,Hydrops Fetalis Nonimmune,Hydrops Fetalis, Idiopathic,Hydrops Fetalis, Immune,Hydrops Fetalis, Non-Immune,Hydrops Fetalis, Nonimmune,Idiopathic Hydrops Fetalis,Immune Hydrops Fetalis,Non-Immune Hydrops Fetalis,Familial Non Immune Hydrops Fetalis,Fetali, Idiopathic Hydrops,Fetalis Nonimmune, Hydrops,Fetalis Nonimmunes, Hydrops,Fetalis, Idiopathic Hydrops,Hydrops Fetali, Idiopathic,Hydrops Fetali, Nonimmune,Hydrops Fetalis Nonimmunes,Hydrops, Fetal,Idiopathic Hydrops Fetali,Nonimmune Hydrops Fetali,Nonimmune Hydrops Fetalis,Nonimmune, Hydrops Fetalis,Nonimmunes, Hydrops Fetalis
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
March 2008, European journal of obstetrics, gynecology, and reproductive biology,
Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
November 2019, Acta obstetricia et gynecologica Scandinavica,
Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
February 2023, American journal of obstetrics & gynecology MFM,
Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
November 2011, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
November 2005, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
September 1987, Asia-Oceania journal of obstetrics and gynaecology,
Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
January 2003, Fetal diagnosis and therapy,
Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
January 2019, Ceska gynekologie,
Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
August 2011, Pediatric surgery international,
Rebecca Horgan, and Julia A Youssef, and Ariel T Levy, and Seth I Berger, and Sophie Dreux, and Maria L Brizot, and Alison Boutall, and Alfred Z Abuhamad, and Ana M Angarita, and Huda B Al-Kouatly
September 2014, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology,
Copied contents to your clipboard!